Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD)
NCT ID: NCT00610831
Last Updated: 2018-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2007-05-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging
NCT03354611
Case Collection Study for Collecting Images for the Development and Validation of Computer Aided Detection Software
NCT00756834
Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer
NCT01303419
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography
NCT02540083
Xpress Digital Mammography System Images for Computer Aided Detection Development
NCT01061138
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DirectView CR Mammography
Each subject will have routine clinical care imaging obtained and 4 standard mammogram views (RMLO, RCC, LMLO, LCC) using CR mammography. If routine mammograms were obtained on a day previous to enrollment in the study, those images (4 views; 2 views for mastectomy patients) will not be repeated for this study; only the CR images will be obtained.
DIRECTVIEW CR Mammography
4 views screening mammogram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DIRECTVIEW CR Mammography
4 views screening mammogram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recommended for biopsy and BI-RADS assessment of category 4 (suspicious abnormality) or 5 (highly suggestive of malignancy)
* Able to have MLO and CC views taken
* Good general health
* Able and willing to provide a written Informed Consent
Exclusion Requirements
* Under age 40
* Pregnant or suspicious of being pregnant
* Breast implants
* Breasts too large to be adequately positioned on a 24 x 30 cassette
* Personal history of breast cancer treated with a lumpectomy
* Unable or unwilling to provide a written Informed Consent form
40 Years
85 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carestream Health, Inc.
INDUSTRY
Eastman Kodak Company
UNKNOWN
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Feig, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Breast Health Center, University of California Irvine Medical Center
Orange, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CH-41914
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
UCI-HS-2007-5519
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.